Racial Disparities Are Narrowing in Use of ERBB2-Targeted Therapies
Differences in the use of targeted therapies between Black and White patients decreased between 2010-2011 and 2018-2019.
Advertisement
Advertisement
Advertisement

Urban Health Weekly